Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a... Read more
View all
Ascendis Pharma
Hellerup, Denmark · Post IPO Debt
Exelixis
Alameda, United States · Post IPO Equity
Artefact
Paris, France · Post IPO Equity
GBT
South San Francisco, United States · Post IPO Debt
Novocure
Saint Helier, Jersey · Post IPO Debt
Exact Sciences
Madison, United States · Post IPO Debt
PacBio
Menlo Park, United States · Post IPO Equity
Amicus Therapeutics
Cranbury Township, United States · Post IPO Debt
Myovant Sciences
Brisbane, United States · Post IPO Debt
HEXO
Ottawa, Canada · Post IPO Debt
MeiraGTx
New York, United States · Post IPO Debt
Algaia
Paris, France · Venture